Search

everythinglearnresearchcommunity

for

Search:↓

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

Notopterygii rhizoma et radix (Qiang Huo) can effectively treat psoriasis by reducing skin symptoms and inflammation.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Dupilumab for eczema may cause hair loss.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Alitretinoin may help treat alopecia areata.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Upadacitinib effectively treated severe hair loss in a child.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Baricitinib improved hair loss and arthritis in a lupus patient.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.